4//SEC Filing
Ban Randy 4
Accession 0001104659-25-014860
CIK 0001609550other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 6:44 PM ET
Size
32.0 KB
Accession
0001104659-25-014860
Insider Transaction Report
Form 4
Ban Randy
See Remarks
Transactions
- Sale
Common Stock
2025-02-13$180.79/sh−1,330$240,447→ 28,013 total - Sale
Common Stock
2025-02-13$182.90/sh−3,242$592,947→ 21,001 total - Sale
Common Stock
2025-02-13$185.84/sh−3,824$710,646→ 11,184 total - Tax Payment
Common Stock
2025-02-09$182.15/sh−314$57,195→ 2,767 total - Award
Common Stock
2025-02-13+5,076→ 7,843 total - Exercise/Conversion
Common Stock
2025-02-13$67.63/sh+25,000$1,690,750→ 32,843 total - Sale
Common Stock
2025-02-13$178.54/sh−2,500$446,340→ 30,343 total - Sale
Common Stock
2025-02-13$179.41/sh−1,000$179,407→ 29,343 total - Sale
Common Stock
2025-02-13$181.90/sh−3,770$685,757→ 24,243 total - Sale
Common Stock
2025-02-13$183.79/sh−2,541$467,016→ 18,460 total - Sale
Common Stock
2025-02-13$184.81/sh−3,452$637,965→ 15,008 total - Sale
Common Stock
2025-02-13$186.96/sh−3,341$624,648→ 7,843 total - Sale
Common Stock
2025-02-13$187.66/sh−584$109,593→ 7,259 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-02-13−25,000→ 0 totalExercise: $67.63Exp: 2029-07-31→ Common Stock (25,000 underlying)
Holdings
- 167(indirect: Held by son)
Common Stock
- 166(indirect: Held by daughter)
Common Stock
Footnotes (14)
- [F1]Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.31 to $184.30. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.33 to $185.31. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.35 to $186.32. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.35 to $187.29. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F14]Fully vested and exercisable.
- [F2]Includes 25 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on December 31, 2024.
- [F3]Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
- [F4]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.08 to $178.93. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.12 to $179.75. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.29 to $181.27. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.30 to $182.26. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.30 to $183.27. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Inspire Medical Systems, Inc.
CIK 0001609550
Entity typeother
Related Parties
1- filerCIK 0001737127
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 6:44 PM ET
- Size
- 32.0 KB